Abacus Planning Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Abacus Planning Group's LLY Position: Q2 2026 in Review
Abacus Planning Group increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $59.3K and bringing the position to 2,527 shares worth $3.03M. The position accounts for 0.37% of the portfolio, ranked #36.
Abacus Planning Group first reported a position in LLY in Q3 2018 and has held it in 30 quarters since. 1,928 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Abacus Planning Group held 2,527 shares of Eli Lilly worth $3.03M as of Q2 2026.
- Abacus Planning Group bought 58 Eli Lilly shares in Q2 2026, an estimated $59.3K.
- Eli Lilly made up 0.37% of Abacus Planning Group's portfolio in Q2 2026, its #36 holding.
- Abacus Planning Group first reported a position in Eli Lilly in Q3 2018 and has held it in 30 quarters since.
- 1,928 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.